EN
The endoplasmic reticulum (ER) interacts and
cooperates with other organelles as a central hub in cellular
homeostasis. In particular, the ER is the first station along the
secretory pathway, where client proteins fold and assemble
before they travel to their final destination elsewhere in the
endomembrane system or outside the cell. Protein folding
and disulfide bond formation go hand in hand in the ER, a
task that is achieved with the help of ER-resident chaperones
and other folding factors, including oxidoreductases that
catalyze disulfide bond formation. Yet, when their combined
effort is in vain, client proteins that fail to fold are disposed of
through ER-associated degradation (ERAD). The ER folding
and ERAD machineries can be boosted through the unfolded
protein response (UPR) if required. Still, protein folding in
the ER may consistently fail when proteins are mutated due
to a genetic defect, which, ultimately, can lead to disease.
Novel developments in all these fields of study and how
new insights ultimately can be exploited for clinical or
biotechnological purposes were highlighted in a rich variety
of presentations at the ER & Redox Club Meeting that was
held in Venice from 15 to 17 April 2015. As such, the meeting
provided the participants an excellent opportunity to mingle
and discuss key advancements and outstanding questions
on ER function in health and disease.